Calidi Biotherapeutics, Inc. (CLDI, CLDWW)
CIK 1855485 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Calidi Biotherapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 19, 2026 | 4 | 0001493152-26-039286 |
| Aug 19, 2026 | 4 | 0001493152-26-039288 |
| Aug 19, 2026 | 4 | 0001493152-26-039291 |
| Aug 19, 2026 | 4 | 0001493152-26-039290 |
| Aug 19, 2026 | 4 | 0001493152-26-039292 |
| Aug 19, 2026 | 4 | 0001493152-26-039289 |
| Aug 19, 2026 | 4 | 0001493152-26-039285 |
| Aug 19, 2026 | 4 | 0001493152-26-039287 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001172661-26-003562 |
| Aug 13, 2026 | 8-K | 0001493152-26-037840 |
| Aug 13, 2026 | 10-Q | 0001493152-26-037847 |
| Jul 31, 2026 | 8-K | 0001493152-26-035666 |
| Jul 16, 2026 | 8-K | 0001493152-26-033594 |
| Jun 29, 2026 | 3 | 0001493152-26-031118 |
| Jun 23, 2026 | 8-K | 0001493152-26-029710 |
| Jun 18, 2026 | 8-K | 0001493152-26-029374 |
| Jun 5, 2026 | DEFA14A | 0001493152-26-027516 |
| May 29, 2026 | 8-K | 0001493152-26-026415 |
| May 15, 2026 | SCHEDULE 13G | 0001172661-26-002136 |
| May 14, 2026 | 8-K | 0001493152-26-023094 |
| May 14, 2026 | 10-Q | 0001493152-26-023140 |
| May 8, 2026 | 8-K | 0001493152-26-022024 |
| Apr 29, 2026 | DEFA14A | 0001493152-26-019636 |
| Apr 29, 2026 | DEF 14A | 0001493152-26-019617 |
| Apr 17, 2026 | PRE 14A | 0001493152-26-017935 |